Get used to the term ‘test strategy’, because it will be more important than ever when the pandemic season resumes in the autumn, says Lone Simonsen, who is an epidemiologist at Roskilde University, according to TV2.
With Pfizer’s pill Paxlovid hopefully available before then (a course of two pills every 12 hours for five days), corona mortality and hospitalization rates should drop by 89 percent – or at least in theory.
Paxlovid’s success rate depends on the patient taking the pills within a few days of getting the disease. Should they wait too long, e.g. before they reach the hospital, it will be almost useless.
And besides: the availability of Paxlovid, which was released last November with rave reviews from the World Health Organization, will depend on the EU.
Negotiations with Pfizer have stalled a bit lately, and the Danish Health and Medicines Authority is now questioning whether it could have been better to pursue an agreement for Denmark alone.
Who, when, where and how much
“The question is how to get these pills out to people fast enough. Because if you do not get it fast enough, it is not worth anything,” warned Simonsen.
“It is so far unclear where you can get the pill, who can get the pill, and whether you can get it after a positive home test. It is also unknown what the price will be. ”
Allan Randrup Thomsen, a virologist at the University of Copenhagen, agrees.
“It is important that we identify who should have the tablet, because it is special target groups that should have the medicine, and that presupposes guidance for the general practitioners,” he added.
200,000 a day possibly
At a press conference today, Minister of Health Magnus Heunicke confirmed that Denmark’s ‘test strategy’ will prioritize PCR tests over rapid tests, which there are no plans to offer at centers.
“We will quickly be able to scale up and perform 200,000 daily PCR tests if necessary,” he said.
As part of the strategy, frontline employees will be encouraged to test themselves twice a week from 15 August.
Heunicke also revealed that anyone over the age of 50 will be offered a fourth dose of vaccine in the early fall.
Source: The Nordic Page